Navigation Links
Genomic Health Announces Positive Preliminary Results from QUASAR Validation Study of Oncotype DX(R) Colon Cancer Assay
Date:4/14/2009

ot obtain or maintain sufficient levels of reimbursement for our tests; the risks and uncertainties associated with the regulation of our tests by FDA; the applicability of clinical study results to actual outcomes; and the other risks set forth in the company's filings with the Securities and Exchange Commission, including the risks set forth in the company's Annual Report on Form 10-K for the year ended December 31, 2008. These forward-looking statements speak only as of the date hereof. Genomic Health disclaims any obligation to update these forward-looking statements.

NOTE: The Genomic Health logo, Oncotype, Oncotype DX and Recurrence Score are trademarks or registered trademarks of Genomic Health, Inc. All other trademarks and service marks are the property of their respective owners.


'/>"/>
SOURCE Genomic Health, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Transgenomic, Inc. Reports Second Quarter 2007 Results
2. Rosetta Genomics Announces Annual General Meeting of Shareholders to be Held on September 24, 2007
3. GeneNews Chief Scientist Dr. C.C. Liew co-editor of new genomics reference book
4. CODA Genomics Announces Issuance of Optimized Synthetic Gene Production Patent
5. Revolutionary Genomics Research Group Opens Boston Office; Provides DNA Evidence in Workers Comp Cases
6. WallSt.net (www.wallst.net) Announces Upcoming Interview With CEO of DNAPrint Genomics
7. NYU Medical Center Collaborates With Rosetta Genomics to Develop a microRNA-Based Diagnostic Test for Melanoma
8. Rosetta Genomics to Present at the American Association of Cancer Research (AACR) "Molecular Diagnostics in Cancer Therapeutic Development" Conference
9. Rosetta Genomics to Webcast Presentation at Maxim Group Growth Conference
10. BioNanoatrix and Complete Genomics Receive $8.8 Million NIST-ATP Award to Develop Sequencing Platform for $100 Genome
11. BioNanomatrix and Complete Genomics Receive $8.8 Million NIST-ATP Award to Develop Sequencing Platform for $100 Genome

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...yendpointhasbeenmetforpatientswithadvanced-stage,o....24/PRNewswire-FirstCall/-AEternaZentarisInc.(NASD...euticalcompanyfocusedonendocrinetherapyandoncology...ywithitstargetedcytotoxicpeptideconjugate,AEZS-108...endometrialcancer.Inapersonalizedhealthcareapproac...
(Date:11/24/2009)...r24/PRNewswire-FirstCall/--Shireplc(LSE:SHP,NASDA...any,today,announcedthatithassubmittedaMAAtotheEuro...y,senzymereplacementtherapyindevelopment,forthetre...g,applicationforvelaglucerasealfathathasbeensubmit...nada. , Basedonaglobalsupplyshortageofthecurr...
(Date:11/24/2009)...lif.,Nov.24/PRNewswire-FirstCall/--GenomicHealth,I...omicHealth,sExecutiveChairman,willpresentatthe21st...yonTuesday,December1,2009at10:00a.m.ET. ,, Toac...entation,visittheInvestorRelationssectionofGenomic...m .Pleaseconnecttothewebsiteatleast15minutespriort...
(Date:11/24/2009)... Program Connects Customers with Partners Valid... DNA Genotek Products , O...k , a leading provider of products for biological ...today announced its new global partner program. Th...Genotek,s partner community and is designed to hel...
Breaking Biology Technology:AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3Genomic Health to Present at Piper Jaffray Health Care Conference 2DNA Genotek Launches Global Partner Program 2DNA Genotek Launches Global Partner Program 3
...organic light-emitting diodes, require a transpare...ning it promotes injection of electron holes into ...ch presented on July 8 at the International Confer... in Brazil provides insight into factors that infl...on of positive and negative charge carriers into t...
...d applications support in plant ...-Aldrich (Nasdaq:,SIAL) and Metahelix Life Science...lix will assist in developing applications data fo...nd provide expert technological guidance,regarding...ur in,Metahelix,s existing facility, located adjac...
... and pharmaceutical,firms are developing a host of...icated drug discovery process, reports Genetic Eng...sful approaches rely on a combination,of high-thro...es, and,advanced data-analysis tools, according to...ews.com/articles/chitem.aspx?aid=2527 ) of GEN., ...
Other Biology Technology:Research helps understand factors that influence efficiency of organic-based devices 2Research helps understand factors that influence efficiency of organic-based devices 3Sigma-Aldrich Announces Collaboration With Metahelix Life Sciences 2Sigma-Aldrich Announces Collaboration With Metahelix Life Sciences 3GEN Reports on Novel Hit-to-Lead Drug Discovery Strategies 2
(Date:11/25/2009)...olice officers and ambulance workers faced a terri...lex. They battled to save people from the collapsi...res and evacuated as many people as they could in .... And making their jobs even harder was the proble...heir relatives jammed mobile networks with calls a...
(Date:11/25/2009)...Soil is the linchpin of the environment, where atm...that, many students see soil as "just dirt" a pla...educators are challenged with the task of helping ...ortance of soil in the environment. , A collabo...eachers at University of Nebraska-Lincoln, Oregon ...
(Date:11/25/2009)...ant professors recently received funding from the ...arch beneficial to understanding the environment. ...lackwood, assistant professor in the Department of...t two separate research projects. , His first pr...ities and Functions from the Leaf to the Landscape...
Breaking Biology News(10 mins):Magic box for mission impossible 2Magic box for mission impossible 3It's not just dirt! 2Kent State University professors focus research on the environment with grants totaling $890,000 2Kidney Care Partners Launches Health Care Campaign to Improve Survival Rates of First Year Dialysis Patients 48197 1Kidney Care Partners Launches Health Care Campaign to Improve Survival Rates of First Year Dialysis Patients 48197 2Kidney Care Partners Launches Health Care Campaign to Improve Survival Rates of First Year Dialysis Patients 48197 3U S Could Save 100 000 Lives a Year with Five Basic Preventive Services 48193 1U S Could Save 100 000 Lives a Year with Five Basic Preventive Services 48193 2Medical Home Pilot Initiatives Continue to Expand Nationwide 48189 1Medical Home Pilot Initiatives Continue to Expand Nationwide 48189 2Medical Home Pilot Initiatives Continue to Expand Nationwide 48189 3
...chool of Medicine and University of Crete School o... first evidence of a molecular mechanism that dyna...k connections. , This discovery may help the devel...s of normal aging, and for cognitive changes in sc...t hyperactivity disorder (ADHD). , "Our data re...
...chers have identified a novel gene mutation that c...was no previously known molecular diagnosis, accor...on Tuesday, March 20, 2007 in The American Journal...nd (Cambridge Institute of Medical Research, Unive...Tarpey (Wellcome Trust Sanger Institute, Hixton, U...
...ists at the University of California, San Diego an...a global map of estimated plant species richness. ...entists say their global map is the most extensive...to date. , The map, which accompanies a study publ...rnal Proceedings of the National Academy of Scienc...
Other Biology News:Brain networks strengthened by closing ion channels 2Brain networks strengthened by closing ion channels 3Severe mental retardation gene mutation identified 2Biologists produce global map of plant biodiversity 2
Goat Anti-Human p27 KIP 1 Polyclonal Antibody, Unconjugated from Abcam
Rabbit Anti-Defender against cell death 1 Polyclonal Antibody, Unconjugated from GenWay Biotech, Inc.
Goat Anti-Wnt-1 (G-19) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Mouse Anti-Angiotensin II Type 1 Receptor Monoclonal Antibody, Unconjugated, Clone TONI-1 from Abcam
Biology Products: